In A Prescription for Change, Michael Kinch, associate vice chancellor and director of the Center for Research Innovation in Biotechnology, tells about the looming crisis in the pharmaceutical industry. Bringing a drug to market costs $2.6 billion, and most pharmaceutical companies have shut down their research and development wings as a result. To keep new drugs coming to market, Kinch argues, we must find ways to lower the cost of producing them.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.